Table of Contents
ISRN Nephrology
Volume 2013, Article ID 324315, 18 pages
http://dx.doi.org/10.5402/2013/324315
Review Article

Glomerular Disease in Patients with Infectious Processes Developing Antineutrophil Cytoplasmic Antibodies

1Division of Rheumatology, Department of Medicine, Raymond G. Murphy VA Medical Center, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA
2Department of Pathology, University of New Mexico School of Medicine, MSC08 4640, BMSB, Room 335, University of New Mexico, Albuquerque, NM 87131, USA
3Division of Infectious Diseases, Department of Medicine, Raymond G. Murphy VA Medical Center, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA
4Division of Nephrology, Department of Medicine, Raymond G. Murphy VA Medical Center, University of New Mexico School of Medicine, VA Medical Center (111C), 1501 San Pedro, SE, Albuquerque, NM 87131, USA

Received 18 October 2012; Accepted 6 November 2012

Academic Editors: G. Gonlusen, M. S. Mubarak, and S. Nasr

Copyright © 2013 Konstantin N. Konstantinov et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. C. Williams Jr. and H. G. Kunkel, “Rheumatoid factor, complement, and conglutinin aberrations in patients with subacute bacterial endocarditis,” The Journal of Clinical Investigation, vol. 41, pp. 666–675, 1962. View at Google Scholar · View at Scopus
  2. M. Lohlein, “Ueber haemorrhagische nierenaffectionen bei chronischer ulcerozer endocarditis,” Medicinische Klinik, vol. 10, pp. 375–379, 1910. View at Google Scholar
  3. K. Lange, G. Seligson, and W. Cronin, “Evidence for the in situ origin of poststreptococcal glomerulonephritis: glomerular localization of endostreptosin and the clinical significance of the subsequent antibody response,” Clinical Nephrology, vol. 19, no. 1, pp. 3–10, 1983. View at Google Scholar · View at Scopus
  4. A. S. Bayer, A. N. Theofilopoulos, and R. Eisenberg, “Circulating immune complexes in infective endocarditis,” New England Journal of Medicine, vol. 295, no. 27, pp. 1500–1505, 1976. View at Google Scholar · View at Scopus
  5. F. J. Dixon, J. D. Feldman, and J. J. Vasquez, “Experimental glomerulonephritis: the pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis,” Journal of Experimental Medicine, vol. 113, pp. 899–920, 1961. View at Google Scholar
  6. R. A. Gutman, G. E. Striker, B. C. Gilliland, and R. E. Cutler, “The immune complex glomerulonephritis of bacterial endocarditis,” Medicine, vol. 51, no. 1, pp. 1–25, 1972. View at Google Scholar · View at Scopus
  7. W. G. Couser, “Mechanisms of glomerular injury in immune-complex disease,” Kidney International, vol. 28, no. 3, pp. 569–583, 1985. View at Google Scholar · View at Scopus
  8. G. O. Perez, N. Rothfield, and R. C. Williams, “Immune complex nephritis in bacterial endocarditis,” Archives of Internal Medicine, vol. 136, no. 3, pp. 334–336, 1976. View at Publisher · View at Google Scholar · View at Scopus
  9. R. L. Levy and R. Hong, “The immune nature of subacute bacterial endocarditis (SBE) nephritis,” The American Journal of Medicine, vol. 54, no. 5, pp. 645–652, 1973. View at Google Scholar · View at Scopus
  10. H. K. Choi, P. A. Merkel, A. M. Walker, and J. L. Niles, “Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis,” Arthritis & Rheumatism, vol. 43, pp. 405–413, 2000. View at Google Scholar
  11. H. H. Peter, D. Metzger, A. Rump, and E. Rother, “ANCA in diseases other than systemic vasculitis,” Clinical and Experimental Immunology, vol. 93, no. 1, supplement, pp. 12–14, 1993. View at Google Scholar · View at Scopus
  12. L. Nassberger, A. G. Sjoholm, H. Jonsson, G. Sturfelt, and A. Akesson, “Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus,” Clinical and Experimental Immunology, vol. 81, no. 3, pp. 380–383, 1990. View at Google Scholar · View at Scopus
  13. N. Makita, H. Katori, F. Takemoto et al., “A case of mixed connective tissue disease (MCTD) complicated with MPO-ANCA-related necrotizincj gloomerulonephritis,” Clinical Nephrology, vol. 54, no. 2, pp. 164–168, 2000. View at Google Scholar · View at Scopus
  14. D. Bansi, R. W. Chapman, and K. Fleming, “Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass,” Journal of Hepatology, vol. 24, no. 5, pp. 581–586, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. R. H. Duerr, S. R. Targan, C. J. Landers et al., “Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis,” Gastroenterology, vol. 100, no. 5 I, pp. 1385–1391, 1991. View at Google Scholar · View at Scopus
  16. D. Zauli, S. Ghetti, A. Grassi et al., “Anti-neutrophilcytoplasmic antibodies in type 1 and 2 autoimmune hepatitis,” Hepatology, vol. 25, no. 5, pp. 1105–1107, 1997. View at Google Scholar · View at Scopus
  17. Y. Hosoya, S. Minota, A. Lefor et al., “Resolution of anti-neutrophil cytoplasmic antibody-associated vasculitis after resection of gastric cancer,” Modern Rheumatology, vol. 20, no. 1, pp. 102–105, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Cil, A. Altintas, A. Isikdogan, and S. Batun, “Prevalence of antineutrophil cytoplasmic antibody positivity in patients with Hodgkin's and non-Hodgkin lymphoma: a single center experience,” International Journal of Hematology, vol. 90, no. 1, pp. 52–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Tsuruoka, S. Sekiya, T. Yokoyama et al., “MPO-ANCA related vasculitis complicating mucinous cystadenoma of the pancreas and severe acute pancreatitis after steroid pulse therapy: a case report,” Japanese Journal of Nephrology, vol. 50, no. 7, pp. 948–953, 2008. View at Google Scholar · View at Scopus
  20. M. Wong, J. Grossman, B. H. Hahn, and A. La Cava, “Cutaneous vasculitis in breast cancer treated with chemotherapy,” Clinical Immunology, vol. 129, no. 1, pp. 3–9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. J. G. Parambil, K. A. Keogh, F. C. Fervenza, and J. H. Ryu, “Microscopic polyangiitis associated with thymoma, exacerbating after thymectomy,” American Journal of Kidney Diseases, vol. 48, no. 5, pp. 827–831, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. D. Navaneethan, J. Taylor, B. Goldman, and A. Bose, “Anti-neutrophil cytoplasmic antibody associated crescentic IgA nephropathy in hematopoietic stem cell transplantation,” Clinical Nephrology, vol. 71, no. 1, pp. 59–62, 2009. View at Google Scholar · View at Scopus
  23. B. Terjung and U. Spengler, “Atypical p-ANCA in PSC and AIH: a hint toward a “leaky gut”?” Clinical Reviews in Allergy and Immunology, vol. 36, no. 1, pp. 40–51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Wada, T. Kuroda, A. Murasawa, M. Nakano, and I. Narita, “Anti-neutrophil cytoplasmic autoantibodies against bactericidal/permeability-increasing protein in patients with rheumatoid arthritis and their correlation with bronchial involvement,” Modern Rheumatology, vol. 20, no. 3, pp. 252–256, 2010. View at Google Scholar · View at Scopus
  25. L. Harper and C. O. Savage, “ANCA-associated renal vasculitis at the end of the twentieth century—a disease of older patients,” Rheumatology, vol. 44, no. 4, pp. 495–501, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. C. A. Langford, “Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis,” Clinical and Experimental Immunology, vol. 164, no. 1, supplement, pp. 31–34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Rees, R. Yazdani, and P. Lanyon, “Long-term follow-up of different refractory systemic vasculitides treated with rituximab,” Clinical Rheumatology, vol. 30, pp. 1241–1245, 2011. View at Google Scholar
  28. A. Majumdar, S. Chowdhary, M. A. S. Ferreira et al., “Renal pathological findings in infective endocarditis,” Nephrology Dialysis Transplantation, vol. 15, no. 11, pp. 1782–1787, 2000. View at Google Scholar · View at Scopus
  29. J. I. Zeledon, R. L. McKelvey, K. S. Servilla et al., “Histological varieties and treatment of glomerulonephritis causing acute renal failure during the course of bacterial infections,” International Urology and Nephrology, vol. 40, no. 2, pp. 461–470, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. R. J. L. Klaassen, R. Goldschmeding, K. M. Dolman et al., “Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection,” Clinical and Experimental Immunology, vol. 87, no. 1, pp. 24–30, 1992. View at Google Scholar · View at Scopus
  31. F. Bonnet, J. J. Pineau, J. L. Taupin et al., “Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients,” Journal of Rheumatology, vol. 30, no. 9, pp. 2005–2010, 2003. View at Google Scholar · View at Scopus
  32. L. H. Calabrese, “Infection with the human immunodeficiency virus type 1 and vascular inflammatory disease,” Clinical and Experimental Rheumatology, vol. 22, no. 6, pp. S87–S93, 2004. View at Google Scholar · View at Scopus
  33. A. Kamat, P. Ancuta, R. S. Blumberg, and D. Gabuzda, “Serological markers for inflammatory bowel disease in aids patients with evidence of microbial translocation,” PLoS ONE, vol. 5, no. 11, Article ID e15533, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. H. K. Choi, P. Lambrecht, K. L. Niles, W. L. Gross, and P. A. Merkel, “Subacute bacterial endocarditis with positive antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies,” Arthritis & Rheumatism, vol. 43, pp. 226–231, 2000. View at Google Scholar
  35. A. De Corla-Souza and B. A. Cunha, “Streptococcal viridans subacute bacterial endocarditis associated with antineutrophil cytoplasmic autoantibodies (ANCA),” Heart and Lung, vol. 32, no. 2, pp. 140–143, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Bonaci-Nikolic, S. Andrejevic, M. Pavlovic, Z. Dimcic, B. Ivanovic, and M. Nikolic, “Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge,” Clinical Rheumatology, vol. 29, no. 8, pp. 893–904, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Guillevin, H. Visser, F. Oksman, and J. Pourrat, “Antineutrophil cytoplasmic antibodies in polyarteritis nodosa related to hepatitis B virus,” Arthritis and Rheumatism, vol. 33, no. 12, pp. 1871–1872, 1990. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Guillevin, H. Visser, L. H. Noel et al., “Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome—62 patients,” Journal of Rheumatology, vol. 20, no. 8, pp. 1345–1349, 1993. View at Google Scholar · View at Scopus
  39. R. Kasmani, K. Okoli, K. Naraharisetty, W. Gunning, J. I. Shapiro, and S. Ratnam, “Microscopic polyangiitis triggered by recurrent methicillin-resistant Staphylococcus aureus bacteremia,” International Urology and Nephrology, vol. 42, no. 3, pp. 821–824, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. S. P. McAdoo, C. Densem, A. Salama, and C. D. Pusey, “Bacterial endocarditis associated with proteinase 3 anti-neutrophil cytoplasm antibody,” NDT Plus, vol. 4, no. 3, pp. 208–210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Romani, L. Puig, and J. N. De Moragas, “Detection of antineutrophil cytoplasmic antibodies in patients with hepatitis C virus-induced cutaneous vasculitis with mixed cryoglobulinemia,” Archives of Dermatology, vol. 132, no. 8, pp. 974–975, 1996. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Ohira, J. Tojo, J. Shinzawa et al., “Antineutrophil cytoplasmic antibody in patients with antinuclear antibody-positive chronic hepatitis C,” Fukushima Journal of Medical Science, vol. 44, no. 2, pp. 83–92, 1998. View at Google Scholar · View at Scopus
  43. P. Lamprecht, O. Gutzeit, E. Csernok et al., “Prevalence of ANCA in mixed cryoglobulinemia and chronic hepatitis C virus infection,” Clinical and Experimental Rheumatology, vol. 21, no. 6, pp. S89–S94, 2003. View at Google Scholar · View at Scopus
  44. M. Cojocaru, I. M. Cojocaru, and S. A. Iacob, “Prevalence of anti-neutrophil cytoplasmic antibodies in patients with chronic hepatitis C infection associated mixed cryoglobulinemia,” Romanian Journal of Internal Medicine, vol. 44, no. 4, pp. 427–431, 2006. View at Google Scholar · View at Scopus
  45. T. N. K. Chou, T. C. Hsu, R. M. Chen, L. I. Lin, and G. J. Tsay, “Parvovirus B19 infection associated with the production of antineutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL),” Lupus, vol. 9, no. 7, pp. 551–554, 2000. View at Google Scholar · View at Scopus
  46. J. Hermann, U. Demel, D. Stünzner, E. Daghofer, G. Tilz, and W. Graninger, “Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall,” Annals of the Rheumatic Diseases, vol. 64, no. 4, pp. 641–643, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. C. M. Magro, R. Wusirika, G. E. Frambach, G. J. Nuovo, C. Ferri, and P. Ross, “Autoimmune-like pulmonary disease in association with parvovirus B19: a clinical, morphologic, and molecular study of 12 cases,” Applied Immunohistochemistry and Molecular Morphology, vol. 14, no. 2, pp. 208–216, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. P. von Landenberg, H. W. Lehmann, and S. Modrow, “Human parvovirus B19 infection and antiphospholipid antibodies,” Autoimmunity Reviews, vol. 6, no. 5, pp. 278–285, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Satake, I. Ohsawa, N. Kobayashi et al., “Three cases of PR3-ANCA positive subacute bacterial endocarditis caused by attenuated bacteria (Propionibacterium, Gemella, and Bartonella) complicated with kidney injury,” Modern Rheumatology, vol. 21, pp. 536–541, 2011. View at Google Scholar
  50. D. J. Davies, J. E. Moran, J. F. Niall, and G. B. Ryan, “Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?” British Medical Journal, vol. 285, no. 6342, article 606, 1982. View at Google Scholar · View at Scopus
  51. A. Bauer, W. J. Jabs, S. Süfke, M. Maass, and B. Kreft, “Vasculitic purpura with antineutrophil cytoplasmic antibody-positive acute renal failure in a patient with Streptococcus bovis and Neisseria subflava bacteremia and subacute endocarditis,” Clinical Nephrology, vol. 62, no. 2, pp. 144–148, 2004. View at Google Scholar · View at Scopus
  52. A. Steitz, T. Orth, A. Feddersen, T. Fischer, E. Marker-Hermann, and M. Husmann, “A case of endocarditis with vasculitis due to Actinobacillus actinomycetemcomitans: a 16S rDNA signature for distinction from related organisms,” Clinical Infectious Diseases, vol. 27, no. 1, pp. 224–225, 1998. View at Google Scholar · View at Scopus
  53. R. Mahadeva, A. C. Dunn, R. C. Westerbeek et al., “Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease,” Clinical and Experimental Immunology, vol. 117, no. 3, pp. 561–567, 1999. View at Publisher · View at Google Scholar · View at Scopus
  54. E. Carmona, F. Perez-Aguilar, J. A. Lopez, J. Ferrer-Calvete, and J. M. Sanchez-Cuenca, “Anti-neutrophil-cytoplasmic auto-antibodies (ANCA) in 105 patients (56 adults and 49 children) suffering from cystic fibrosis, attending a Spanish hospital,” Journal of Internal Medicine, vol. 252, no. 3, pp. 281–282, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Dorlöchter, M. Carlsson, E. J. Olafsdottir, O. D. RoØksund, K. Rosendahl, and G. Fluge, “Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis,” Journal of Cystic Fibrosis, vol. 3, no. 3, pp. 179–183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Rotschild, N. Elias, D. Berkowitz et al., “Autoantibodies against bactericidal/permeability-increasing protein (BPI-ANCA) in cystic fibrosis patients treated with azithromycin,” Clinical and Experimental Medicine, vol. 5, no. 2, pp. 80–85, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. O. Cohavy, D. Bruckner, L. K. Gordon et al., “Colonic bacteria express an ulcerative colitis pANCA-related protein epitope,” Infection and Immunity, vol. 68, no. 3, pp. 1542–1548, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Locht, E. Peen, and T. Skogh, “Antineutrophil cytoplasmic antibodies in reactive arthritis,” Journal of Rheumatology, vol. 22, no. 12, pp. 2304–2306, 1995. View at Google Scholar · View at Scopus
  59. K. Zycinska, K. A. Wardyn, Z. Zycinski, and R. Smolarczyk, “Correlation between Helicobacter pylori infection and pulmonary wegener's granulomatosis activity,” Journal of Physiology and Pharmacology, vol. 59, no. 6, pp. 845–851, 2008. View at Google Scholar · View at Scopus
  60. H. Schultz, E. Csernok, S. Nikkari, P. Toivanen, A. Toivanen, and W. L. Gross, “BPI-ANCA is found in reactive arthritis caused by Yersinia and Salmonella infection and recognise exclusively the C-terminal part of the BPI molecule,” Scandinavian Journal of Rheumatology, vol. 29, no. 4, pp. 226–231, 2000. View at Publisher · View at Google Scholar · View at Scopus
  61. C. Bechara, M. Gousseff, A. Passeron et al., “Corynebacterium jeikeium pacemaker infection associated with antineutrophil cytoplasmic antibodies: a single positive blood culture could be sufficient for diagnosis,” Journal of Medical Microbiology, vol. 60, no. 2, pp. 249–251, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Park, S. Banno, Y. Sugiura et al., “Microscopic polyangiitis associated with diffuse panbronchiolitis,” Internal Medicine, vol. 43, no. 4, pp. 331–335, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. E. K. Bell, S. S. Chugh, and W. J. Cook, “A case of infection-associated antiproteinase-3-negative cytoplasmic antineutrophil cytoplasmic antibody pauci-immune focal necrotizing glomerulonephritis,” Nephrology Dialysis Transplantation, vol. 25, no. 9, pp. 3119–3123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. K. Trcko, P. B. Marko, and J. Milijkovic, “Leucocytoclastic vasculitis induced by Mycoplasma pneumoniae infection,” Acta Dermatovenerologica Croatica, vol. 20, pp. 118–121, 2012. View at Google Scholar
  65. M. Iyoda, T. Hato, K. Matsumoto et al., “Rapidly progressive glomerulonephritis in a patient with Chlamydia pneumoniae infection: a possibility of superantigenic mechanism of its pathogenesis,” Clinical Nephrology, vol. 65, no. 1, pp. 48–52, 2006. View at Google Scholar · View at Scopus
  66. M. Iyoda, A. Kuroki, and T. Sugisaki, “Chlamydia pneumoniae infection and MPO-ANCA-associated glomerulonephritis,” Nephrology Dialysis Transplantation, vol. 22, no. 3, pp. 965–966, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Fujita, S. Hatachi, and M. Yagita, “Acute Chlamydia pneumoniae infection in the pathogenesis of autoimmune diseases,” Lupus, vol. 18, no. 2, pp. 164–168, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. G. Cabiddu, P. Altieri, A. Pani et al., “Mediterranean spotted fever with acute renal failure simulating a relapse in C-ANCA vasculitis,” Nephron, vol. 79, no. 2, pp. 241–242, 1998. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Garcia-Zamalloa, N. Gurruchaga, and M. Montes, “Q fever and antineutrophil cytoplasmic antibodies,” American Journal of Medicine, vol. 108, no. 8, pp. 687–688, 2000. View at Publisher · View at Google Scholar · View at Scopus
  70. R. O. Holmes Jr., J. D. Hartzell, J. K. Tofferi, J. D. Roebuck, and W. F. Kelly, “Dual high titer antineutrophil cytoplasmic autoantibodies in association with systemic Q fever,” Journal of Clinical Rheumatology, vol. 15, no. 8, pp. 411–413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. W. Wöckel, K. Häußinger, R. Weis, and A. Morresi-Hauf, “Anticytoplasmatic antibody (cANCA) in syphilitic gumma of the lung,” Deutsche Medizinische Wochenschrift, vol. 121, no. 19, pp. 617–621, 1996. View at Google Scholar · View at Scopus
  72. A. Constantin, F. Marin, F. Oksman, and G. Bouteiller, “Antineutrophil cytoplasmic antibodies in leptospirosis,” The Journal of Rheumatology, vol. 23, no. 2, article 411, 1996. View at Google Scholar · View at Scopus
  73. B. F. A. Freire, A. A. F. Ferraz, E. Nakayama, S. Ura, and T. T. Queluz, “Anti-neutrophil cytoplasmic antibodies (ANCA) in the clinical forms of leprosy,” International Journal of Leprosy, vol. 66, no. 4, pp. 475–482, 1998. View at Google Scholar · View at Scopus
  74. F. Medina, A. Camargo, J. Moreno, A. Zonana-Nacach, J. Aceves-Avila, and A. Fraga, “Anti-neutrophil cytoplasmic autoantibodies in leprosy,” British Journal of Rheumatology, vol. 37, no. 3, pp. 270–273, 1998. View at Google Scholar · View at Scopus
  75. O. Cohavy, G. Harth, M. Horwitz et al., “Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease,” Infection and Immunity, vol. 67, no. 12, pp. 6510–6517, 1999. View at Google Scholar · View at Scopus
  76. V. D. Pradhan, S. S. Badakere, K. Ghosh, and A. R. Pawar, “Spectrum of anti-neutrophil cytoplasmic antibodies in patients with Pulmonary Tuberculosis overlaps with that of Wegener's granulomatosis,” Indian Journal of Medical Sciences, vol. 58, no. 7, pp. 283–288, 2004. View at Google Scholar · View at Scopus
  77. S. Chaiamnuay and L. W. Heck, “Antineutrophil cytoplasmic antibody vasculitis associated with Mycobacterium avium intracellulare infection,” Journal of Rheumatology, vol. 32, no. 8, pp. 1610–1612, 2005. View at Google Scholar · View at Scopus
  78. F. L. B. Edington, M. O. A. R. Bacellar, P. R. Machado et al., “Anti-neutrophil cytoplasmic antibodies in leprosy,” Clinical Rheumatology, vol. 26, no. 2, pp. 208–210, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Faruqi, J. A. Kastelik, and D. V. McGivern, “Diagnostic pitfall: Mycobacterium avium complex pulmonary infection and positive ANCA,” European Journal of Internal Medicine, vol. 19, no. 3, pp. 216–218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. K. Ghosh, V. Pradhan, and K. Ghosh, “Background noise of infection for using ANCA as a diagnostic tool for vasculitis in tropical and developing countries,” Parasitology Research, vol. 102, no. 5, pp. 1093–1095, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. R. Sherkat, K. Mostafavizadeh, L. Zeydabadi, P. Shoaei, and S. Rostani, “Antineutrophil cytoplasmic antibodies in patients with pulmonary tuberculosis,” Iranian Journal of Immunology, vol. 8, pp. 52–57, 2011. View at Google Scholar
  82. M. Kontic, S. Radovanovic, M. Nicolic, and B. Bonaci-Nicolic, “Concomitant drug- and infection-induced antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis with multispecific ANCA,” Medical Practice, vol. 21, pp. 488–491, 2012. View at Google Scholar
  83. A. M. Milesi-Lecat, O. Aumaitre, T. Deusebis et al., “Semi-invasive pulmonary aspergillosis with anti-neutrophil cytoplasmic auto-antibodies: two cases,” Annales de Medecine Interne, vol. 145, no. 2, pp. 140–146, 1994. View at Google Scholar · View at Scopus
  84. C. Cho, A. Asuncion, and A. H. Tatum, “False-positive antineutrophil cytoplasmic antibody in aspergillosis with oxalosis,” Archives of Pathology and Laboratory Medicine, vol. 119, no. 6, pp. 558–561, 1995. View at Google Scholar · View at Scopus
  85. T. Akimoto, O. Saito, M. Inoue et al., “Rapid formation of Aspergillus mycetoma in a patient receiving corticosteroid treatment. Serial radiographic observation over two months,” Internal Medicine, vol. 46, no. 11, pp. 733–738, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. T. Saito, N. Shime, K. Itoh et al., “Disseminated aspergillosis following resolution of Pneumocystis pneumonia with sustained elevation of beta-glucan in an intensive care unit: a case report,” Infection, vol. 37, no. 6, pp. 547–550, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. G. E. Mead, D. Wilks, K. McLaren, and R. J. Fergusson, “Oral histoplasmosis: a case report,” Journal of Infection, vol. 37, no. 1, pp. 73–75, 1998. View at Publisher · View at Google Scholar · View at Scopus
  88. R. P. Byrd, J. Hourany, C. Cooper, and T. M. Roy, “False-positive antineutrophil cytoplasmic antibodies in a patient with cavitary pulmonary sporotrichosis,” American Journal of Medicine, vol. 104, no. 1, pp. 101–103, 1998. View at Publisher · View at Google Scholar · View at Scopus
  89. R. H. Evans, C. Gelder M, A. P. Smith, and A. R. Freedman, “Pneumocystis carinii pneumonia mimicking Wegener's granulomatosis,” Clinical Infectious Diseases, vol. 28, no. 5, pp. 1163–1164, 1999. View at Google Scholar · View at Scopus
  90. N. Takeda, H. Ichiyasu, A. Kijima, D. Notsute, N. Saita, and H. Kohrogi, “A case of AIDS with Pneumocystis jirovecii pneumonia which required differentiation from ANCA-related lung disease,” Nihon Kokyuki Gakkai Zasshi, vol. 49, pp. 929–935, 2011. View at Google Scholar
  91. I. Stappaerts, J. Bogers, D. Ebo, E. Vanden Broecke, W. J. Stevens, and P. Vermeire, “c-ANCA positivity in a Belgian patient with pulmonary paracoccidioidomycosis,” European Respiratory Journal, vol. 10, no. 10, pp. 2419–2422, 1997. View at Publisher · View at Google Scholar · View at Scopus
  92. C. Hartman, R. Eliakim, and R. Shamir, “Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease,” Israel Medical Association Journal, vol. 6, no. 4, pp. 221–226, 2004. View at Google Scholar · View at Scopus
  93. G. E. Reese, V. A. Constantinides, C. Simillis et al., “Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease,” American Journal of Gastroenterology, vol. 101, no. 10, pp. 2410–2422, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. D. J. Pudifin, J. Duursma, V. Gathiram, and T. F. H. G. Jackson, “Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody,” Clinical and Experimental Immunology, vol. 97, no. 1, pp. 48–51, 1994. View at Google Scholar · View at Scopus
  95. S. Arslan, A. Bakkaloglu, G. Oksuzoglu et al., “The value of p-ANCA as a serological marker in diagnosing the coexistence of chronic active invasive amebic colitis and ulcerative colitis,” American Journal of Gastroenterology, vol. 90, no. 12, pp. 2265–2266, 1995. View at Google Scholar · View at Scopus
  96. C. Wenisch, H. Wenisch, H. Bankl -C et al., “Detection of anti-neutrophil cytoplasmic antibodies after acute Plasmodium falciparum malaria,” Clinical and Diagnostic Laboratory Immunology, vol. 3, pp. 132–134, 1996. View at Google Scholar
  97. T. M. Yahya, S. Benedict, A. Shalabi, and R. Bayoumi, “Anti-neutrophil cytoplasmic antibody (ANCA) in malaria is directed against cathepsin G,” Clinical and Experimental Immunology, vol. 110, no. 1, pp. 41–44, 1997. View at Google Scholar · View at Scopus
  98. V. Pradhan, S. S. Badakere, U. Shankarkumar, Y. S. Iyer, K. Ghosh, and D. Karnad, “Anti-neutrophil Cytoplasmic Antibodies (ANCA) in Malaria,” Indian Journal of Malariology, vol. 39, no. 3-4, pp. 51–59, 2002. View at Google Scholar · View at Scopus
  99. E. Brahn, D. A. Pegues, Q. Yao, and N. Craft, “Mucocutaneous leishmaniasis masquerading as wegener granulomatosis,” Journal of Clinical Rheumatology, vol. 16, no. 3, pp. 125–128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. F. G. De Rosa, A. Amoroso, A. Teggi et al., “Anti-neutrophil cytoplasmic antibodies in Echinococcus granulosus hydatid disease,” Human Immunology, vol. 62, no. 10, pp. 1122–1126, 2001. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Rajapurkar, U. Hegde, M. Rokhade, S. Gang, and K. Gohel, “Respiratory hyperinfection with Strongyloides stercoralis in a patient with renal failure,” Nature Clinical Practice Nephrology, vol. 3, no. 10, pp. 573–577, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. S. Kaya, M. Demirci, E. Sesli Cetin et al., “Investigation of the presence of autoantibodies in patients with toxocariasis,” Mikrobiyoloji Bülteni, vol. 43, pp. 661–666, 2009. View at Google Scholar
  103. J. Wagner, K. Andrassy, and E. Ritz, “Is vasculitis in subacute bacterial endocarditis associated with ANCA?” Lancet, vol. 337, no. 8744, pp. 799–800, 1991. View at Google Scholar · View at Scopus
  104. L. Couzi, D. Morel, C. Deminière, and P. Merville, “An unusual endocarditis-induced crescentic glomerulonephritis treated by plasmapheresis,” Clinical Nephrology, vol. 62, no. 6, pp. 461–465, 2004. View at Google Scholar · View at Scopus
  105. M. Fukuda, M. Motokawa, T. Usami et al., “PR3-ANCA-positive crescentic necrotizing glomerulonephritis accompanied by isolated pulmonic valve infective endocarditis, with reference to previous reports of renal pathology,” Clinical Nephrology, vol. 66, no. 3, pp. 202–209, 2006. View at Google Scholar · View at Scopus
  106. N. Kishimoto, Y. Mori, H. Yamahara et al., “Cytoplasmic antineutrophil cytoplasmic antibody positive pauci-immune glomerulonephritis associated with infectious endocarditis,” Clinical Nephrology, vol. 66, no. 6, pp. 447–454, 2006. View at Google Scholar · View at Scopus
  107. K. N. Konstantinov, A. A. Harris, M. F. Hartshorne, and A. H. Tzamaloukas, “Symptomatic anti-neutrophil cytoplasmic antibody-positive disease complicating subacute bacterial endocarditis: to treat or not to treat?” Case Reports in Nephrology and Urology, vol. 2, pp. 25–32, 2012. View at Google Scholar
  108. R. Angangco, S. Thiru, and D. B. G. Oliveira, “Pauci-immune glomerulonephritis associated with bacterial infection,” Nephrology Dialysis Transplantation, vol. 8, no. 8, pp. 754–756, 1993. View at Google Scholar · View at Scopus
  109. W. Hanf, J. E. Serre, J. H. Salmon et al., “Glomerulonephrite rapidement progressive a ANCA revelant une endocardite infectieuse subaigue (Rapidly progressive ANCA positive glomerulonephritis as the presenting feature of infectious endocarditis),” La Revue de Médecine Interne, vol. 32, pp. e116–e118, 2011. View at Google Scholar
  110. B. Chan, V. d'Intini, and J. Savige, “Anti-neutrophil cytoplasmic antibody (ANCA)-associated microscopic polyangiitis following a suppurative wound infection,” Nephrology Dialysis Transplantation, vol. 21, no. 10, pp. 2993–2994, 2006. View at Publisher · View at Google Scholar · View at Scopus
  111. M. Uh, I. A. McCormick, and J. T. Kelsall, “Positive cytoplasmic antineutrophil cytoplasmic antigen with PR3 specificity glomerulonephritis in a patient with subacute bacterial endocarditis,” Journal of Rheumatology, vol. 38, no. 7, pp. 1527–1528, 2011. View at Publisher · View at Google Scholar · View at Scopus
  112. J. F. Viallard, S. Bonnet, L. Couzi et al., “Glomerulonephritis caused by Actinobacillus actinomycetemcomitans mimicking c-ANCA-positive vasculitis,” Nephrology Dialysis Transplantation, vol. 17, no. 4, pp. 663–665, 2002. View at Google Scholar · View at Scopus
  113. H. Sugiyama, M. Sahara, Y. Imai et al., “Infective endocarditis by Bartonella quintana masquerading as antineutrophil cytoplasmic antibody-associated small vessel vasculitis,” Cardiology, vol. 114, no. 3, pp. 208–211, 2009. View at Publisher · View at Google Scholar · View at Scopus
  114. S. H. Forbes, S. C. Robert, J. E. Martin, and R. Rajakariar, “Acute kidney injury with hematuria, a positive ANCA test, and low levels of complement,” American Journal of Kidney Diseases, vol. 59, pp. 26–31, 2012. View at Google Scholar
  115. A. Y. Elzouki, M. Akthar, and K. Mirza, “Brucella endocarditis associated with glomerulonephritis and renal vasculitis,” Pediatric Nephrology, vol. 10, no. 6, pp. 748–751, 1996. View at Publisher · View at Google Scholar · View at Scopus
  116. H. Bonarek, F. Bonnet, C. Delclaux, C. Deminière, V. De Précigout, and M. Aparicio, “Reversal of c-ANCA positive mesangiocapillary glomerulonephritis after removal of an infected cysto-atrial shunt,” Nephrology Dialysis Transplantation, vol. 14, no. 7, pp. 1771–1773, 1999. View at Publisher · View at Google Scholar · View at Scopus
  117. Y. Iwata, S. Ohta, K. Kawai et al., “Shunt nephritis with positive titers for ANCA specific for proteinase 3,” American Journal of Kidney Diseases, vol. 43, no. 5, pp. e11–e16, 2004. View at Google Scholar · View at Scopus
  118. T. Nagashima, D. Hirata, H. Yamamoto, H. Okazaki, and S. Minota, “Antineutrophil cytoplasmic autoantibody specific for proteinase 3 in a patient with shunt nephritis induced by Gemella morbillorum,” American Journal of Kidney Diseases, vol. 37, no. 5, article E38, 2001. View at Google Scholar · View at Scopus
  119. H. Takato, M. Yasui, Y. Waseda, N. Sakai, T. Wada, and M. Fujimura, “A case of microscopic polyangiitis following mycoplasma infection in a patient with MPO-ANCA positive pulmonary fibrosis,” Allergology International, vol. 60, no. 1, pp. 93–96, 2011. View at Publisher · View at Google Scholar · View at Scopus
  120. P. Lamprecht, W. H. Schmitt, and W. L. Gross, “Mixed cryoglobulinaemia, glomerulonephritis, and ANCA: essential cryoglobulinaemic vasculitis or ANCA-associated vasculitis?” Nephrology Dialysis Transplantation, vol. 13, no. 1, pp. 213–221, 1998. View at Publisher · View at Google Scholar · View at Scopus
  121. E. J. B. Monteiro, D. Caron, C. A. Balda, M. Franco, A. B. Pereira, and G. M. Kirsztajn, “Anti-glomerular basement membrane glomerulonephritis in an HIV positive patient: case report,” Brazilian Journal of Infectious Diseases, vol. 10, no. 1, pp. 55–58, 2006. View at Publisher · View at Google Scholar · View at Scopus
  122. J. H. Song, K. J. Lee, S. W. Lee, J. Y. Han, and M. J. Kim, “Fatal pulmonary-renal syndrome manifested with immune complex crescentic glomerulonephritis in a patient with MPO-ANCA seropositivity,” Yonsei Medical Journal, vol. 42, no. 4, pp. 425–430, 2001. View at Google Scholar · View at Scopus
  123. T. Messiaen, C. Lefebvre, F. Zech, J. P. Cosyns, and M. Jadoul, “ANCA-positive rapidly progressive glomerulonephritis: there may be more to the diagnosis than you think!,” Nephrology Dialysis Transplantation, vol. 12, no. 4, pp. 839–841, 1997. View at Publisher · View at Google Scholar · View at Scopus
  124. J. F. Subra, C. Michelet, J. Laporte et al., “The presence of cytoplasmic antineutrophil cytoplasmic antibodies (C-ANCA) in the course of subacute bacterial endocarditis with glomerular involvement, coincidence or association?” Clinical Nephrology, vol. 49, no. 1, pp. 15–18, 1998. View at Google Scholar · View at Scopus
  125. T. Haseyama, H. Imai, A. Komatsuda et al., “Proteinase-3-antineutrophil cytoplasmic antibody (PR3-ANCA) positive crescentic glomerulonephritis in a patient with Down's syndrome and infectious endocarditis,” Nephrology Dialysis Transplantation, vol. 13, no. 8, pp. 2142–2146, 1998. View at Publisher · View at Google Scholar · View at Scopus
  126. K. Osafune, H. Takeoka, H. Kanamori et al., “Crescentic glomerulonephritis associated with infective endocarditis: renal recovery after immediate surgical intervention,” Clinical and Experimental Nephrology, vol. 4, no. 4, pp. 329–334, 2000. View at Publisher · View at Google Scholar · View at Scopus
  127. K. Y. Wang, S. Shimajirt, T. Yoshida, S. Yamada, and Y. Sasagurt, “An autopsy case of microscopic polyangiitis associated with bacterial endocarditis,” Journal of University of Occupational and Environmental Health, vol. 32, no. 3, pp. 273–279, 2010. View at Google Scholar · View at Scopus
  128. D. Sitara and B. I. Hoffbrand, “Chronic bronchial suppuration and antineutrophil cytoplasmic antibody (ANCA) positive systemic vasculitis,” Postgraduate Medical Journal, vol. 66, no. 778, pp. 669–671, 1990. View at Google Scholar · View at Scopus
  129. M. Haas and J. A. Eustace, “Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases,” Kidney International, vol. 65, no. 6, pp. 2145–2152, 2004. View at Publisher · View at Google Scholar · View at Scopus
  130. F. Yu, M. Chen, S. X. Wang, W. Z. Zou, M. H. Zhao, and H. Y. Wang, “Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney,” Nephrology, vol. 12, no. 1, pp. 74–80, 2007. View at Publisher · View at Google Scholar · View at Scopus
  131. L. Cavagna, R. Caporali, C. Esposito, C. Augetti, O. Epis, and C. Montecucco, “Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases,” Scandinavian Journal of Rheumatology, vol. 36, no. 1, pp. 74–76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  132. Y. Hirai, M. Iyoda, T. Shibata et al., “Lupus nephritis associated with positive MPO-ANCA in a patient with underlying autoimmune hemolytic anemia,” Clinical and Experimental Nephrology, vol. 12, no. 5, pp. 393–397, 2008. View at Publisher · View at Google Scholar · View at Scopus
  133. S. H. Nasr, V. D. D’Agati, H.-R. Park et al., “Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic seropositivivity,” Clinical Journal of the American Society of Nephrology, vol. 3, pp. 682–690, 2008. View at Google Scholar
  134. S. Mezzano, G. Valderrama, F. Olavarria et al., “Antineutrophil-cytoplasmic-autoantibodies in poststreptococcal nephritis,” Advances in Experimental Medicine and Biology, vol. 336, pp. 449–453, 1993. View at Google Scholar · View at Scopus
  135. A. Waters, V. Langlois, P. Thorner, and D. Geary, “Atypical p-ANCA is not a poor prognostic marker in postinfectious glomerulonephritis,” Pediatric Nephrology, vol. 22, no. 9, pp. 1383–1386, 2007. View at Publisher · View at Google Scholar · View at Scopus
  136. L. G. Ardiles, G. Valderrama, P. Moya, and S. A. Mezzano, “Incidence and studies on antigenic specificities of antineutrophil-cytoplasmic autoantibodies (ANCA) in poststreptococcal glomerulonephritis,” Clinical Nephrology, vol. 47, no. 1, pp. 1–5, 1997. View at Google Scholar · View at Scopus
  137. I. Neumann, H. Regele, R. Kain, R. Birck, and F. T. Meisl, “Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis,” Nephrology Dialysis Transplantation, vol. 18, no. 3, pp. 524–531, 2003. View at Publisher · View at Google Scholar · View at Scopus
  138. S. H. Nasr, S. M. Said, A. M. Valeri et al., “Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 2, pp. 299–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  139. E. Wechsler, T. Yang, S. C. Jordan, A. Vo, and C. C. Nast, “Anti-glomerular basement membrane disease in an HIV-infected patient,” Nature Clinical Practice Nephrology, vol. 4, no. 3, pp. 167–171, 2008. View at Publisher · View at Google Scholar · View at Scopus
  140. P. Singh, M. Barry, and A. Tzamaloukas, “Goodpasture’s disease complicating human immunodeficiency virus infection,” Clinical Nephrology, vol. 76, pp. 74–77, 2011. View at Google Scholar
  141. A. Davenport, J. Goodfellow, S. Goel, A. G. Maciver, and P. Walker, “Aortic valve disease in patients with Wegener's granulomatosis,” American Journal of Kidney Diseases, vol. 24, no. 2, pp. 205–208, 1994. View at Google Scholar · View at Scopus
  142. A. D. Fox and S. E. Robbins, “Aortic valvulitis complicating Wegener's granulomatosis,” Thorax, vol. 49, no. 11, pp. 1176–1177, 1994. View at Google Scholar · View at Scopus
  143. S. C. D. Grant, R. D. Levy, M. C. Venning, C. Ward, and N. H. Brooks, “Wegener's granulomatosis and the heart,” British Heart Journal, vol. 71, no. 1, pp. 82–86, 1994. View at Google Scholar · View at Scopus
  144. N. E. R. Goodfield, S. Bhandari, W. D. Plant, A. Morley-Davies, and G. R. Sutherland, “Cardiac involvement in Wegener's granulomatosis,” British Heart Journal, vol. 73, no. 2, pp. 110–115, 1995. View at Google Scholar · View at Scopus
  145. R. D. Leff, “Acute aortic insufficiency associated with Wegener granulomatosis,” Mayo Clinic Proceedings, vol. 74, no. 9, pp. 897–899, 1999. View at Google Scholar · View at Scopus
  146. P. Bruno, C. Le Hello, M. Massetti et al., “Necrotizing granulomata of the aortic valve in Wegener's disease,” Journal of Heart Valve Disease, vol. 9, no. 5, pp. 633–635, 2000. View at Google Scholar · View at Scopus
  147. J. M. Mishell, “Cases from the Osler Medical Service at Johns Hopkins University,” American Journal of Medicine, vol. 113, no. 7, pp. 607–609, 2002. View at Publisher · View at Google Scholar · View at Scopus
  148. M. Calachanis, P. Ferrero, F. Orzan, F. Marchisio, and G. Trevi, “Vasculitis mimicking bacterial endocarditis,” Italian Heart Journal, vol. 4, no. 11, pp. 816–818, 2003. View at Google Scholar · View at Scopus
  149. C. Stöllberger, J. Finsterer, G. J. Zlabinger et al., “Antineutrophil cytoplasmic autoantibody-negative antiproteinase 3 syndrome presenting as vasculitis, endocarditis, polyneuropathy and Dupuytren's contracture,” Journal of Heart Valve Disease, vol. 12, no. 4, pp. 530–534, 2003. View at Google Scholar · View at Scopus
  150. S. Ramakrishnan, R. Narang, G. C. Khilnani et al., “Wegener's granulomatosis mimicking prosthetic valve endocarditis,” Cardiology, vol. 102, no. 1, pp. 35–36, 2004. View at Publisher · View at Google Scholar · View at Scopus
  151. J. A. Savige, L. Chang, S. Horn, and S. M. Crowe, “Anti-nuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals,” Autoimmunity, vol. 18, no. 3, pp. 205–211, 1994. View at Google Scholar · View at Scopus
  152. G. T. Hernandez, J. M. Critchfield, and R. A. Rodriguez, “Interpretation of serologic tests in an HIV-infected patient with kidney disease,” Nature Clinical Practice Nephrology, vol. 2, no. 12, pp. 708–712, 2006. View at Publisher · View at Google Scholar · View at Scopus
  153. L. A. Szczech, A. Anderson, C. Ramers et al., “The uncertain significance of anti-glomerular basement membrane antibody among HIV-infected persons with kidney disease,” American Journal of Kidney Diseases, vol. 48, no. 4, pp. e55–e59, 2006. View at Publisher · View at Google Scholar · View at Scopus
  154. M. P. Muthiah, “New lung lesion in immunocompromised host—correct diagnosis despite a false positive ANCA,” Southern Medical Journal, vol. 99, no. 7, pp. 701–702, 2006. View at Publisher · View at Google Scholar · View at Scopus
  155. M. Koselj-Kajtna, M. Koselj, T. Rott, A. Kandus, and A. Bren, “Infectious complications of immunosuppressive treatment for anti-neutrophil cytoplasm antibody-related vasculitis,” Transplantation Proceedings, vol. 34, no. 7, pp. 3001–3002, 2002. View at Publisher · View at Google Scholar · View at Scopus
  156. C. Charlier, C. Henegar, O. Launay et al., “Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients,” Annals of the Rheumatic Diseases, vol. 68, no. 5, pp. 658–663, 2009. View at Publisher · View at Google Scholar · View at Scopus
  157. J. G. McGregor, S. L. Hogan, Y. Hu, C. E. Jennette, R. J. Falk, and P. H. Nachman, “Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease,” Clinical Journal of the American Society of Nephrology, vol. 7, pp. 240–247, 2012. View at Google Scholar
  158. Y. Nagaba, Y. Hiki, T. Aoyama et al., “Effective antibiotic treatment of methicillin-resistant Staphylococcus aureus-associated glomerulonephritis,” Nephron, vol. 92, no. 2, pp. 297–303, 2002. View at Google Scholar · View at Scopus
  159. D. Jovanović, Z. Kovacević, V. Rabrenović, and V. Skatarić, “Acute post-streptococcal glomerulonephritis in adults—corticosteroid therapy, yes or no?” Vojnosanitetski Pregled, vol. 58, no. 2, pp. 161–166, 2001. View at Google Scholar · View at Scopus
  160. V. Le Moing, F. Lacassin, M. Delahousse et al., “Use of corticosteroids in glomerulonephritis related to infective endocarditis: three cases and review,” Clinical Infectious Diseases, vol. 28, no. 5, pp. 1057–1061, 1999. View at Google Scholar · View at Scopus
  161. D. Koya, K. Shibuya, R. Kikkawa, and M. Haneda, “Successful recovery of infective endocarditis-induced rapidly progressive glomerulonephritis by steroid therapy combined with antibiotics: a case report,” BMC Nephrology, vol. 5, article 18, 2004. View at Publisher · View at Google Scholar · View at Scopus
  162. A. S. Wiik, “Autoantibodies in ANCA-associated vasculitis,” Rheumatic Disease Clinics, vol. 36, pp. 479–489, 2010. View at Google Scholar
  163. C. G. M. Kallenberg, “Pathogenesis of ANCA-associated vasculitides,” Annals of the Rheumatic Diseases, vol. 70, no. 1, supplement, pp. i59–i63, 2011. View at Publisher · View at Google Scholar · View at Scopus
  164. N. Lepse, W. H. Abdulahad, C. G. M. Kallenberg, and P. Heeringa, “Immune regulatory mechanisms in ANCA-associated vasculitides,” Autoimmunity Reviews, vol. 11, pp. 77–83, 2011. View at Google Scholar
  165. M. M. van Timmeren and P. Heeringa, “Pathogenesis of ANCA-associated vasculitis: recent insights from animal models,” Current Opinion in Rheumatology, vol. 24, pp. 8–14, 2012. View at Google Scholar
  166. M. A. Little, B. Al-Ani, S. Ren et al., “Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system,” PLoS One, vol. 7, Article ID e28626, 2012. View at Google Scholar
  167. Y. Hong, D. Eleftheriou, A. A. Hussain et al., “Anti-neutrophil cytoplasmic antibodies stimulate release on neutrophil microparticles,” Journal of the American Society of Nephrology, vol. 23, pp. 49–62, 2012. View at Google Scholar
  168. C. A. Stegeman, J. W. C. Tervaert, W. J. Sluiter, W. L. Manson, P. E. De Jong, and C. G. M. Kallenberg, “Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis,” Annals of Internal Medicine, vol. 120, no. 1, pp. 12–17, 1994. View at Google Scholar · View at Scopus
  169. M. Laudien, S. D. Gadola, R. Podschun et al., “Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener’s granulomatosis as compared to rheumatoid arthritis and chronic rhinosinusitis with nasal polyps,” Clinical and Experimental Rheumatology, vol. 28, supplement 57, pp. 51–55, 2010. View at Google Scholar
  170. E. R. Popa, C. A. Stegeman, C. G. M. Kallenberg, and J. W. C. Tervaert, “Staphylococcus aureus and Wegener's granulomotosis,” Arthritis Research, vol. 4, no. 2, pp. 77–79, 2002. View at Publisher · View at Google Scholar · View at Scopus
  171. M. Chen and C. G. M. Kallenberg, “ANCA-associated vasculitides-advances in pathogenesis and treatment,” Nature Reviews Rheumatology, vol. 6, no. 11, pp. 653–664, 2010. View at Publisher · View at Google Scholar · View at Scopus
  172. J. Savige, L. Nassis, T. Cooper, B. Paspaliaris, P. Martinello, and D. MacGregor, “Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunization with bacterial proteins,” Clinical and Experimental Rheumatology, vol. 20, pp. 783–789, 2002. View at Google Scholar
  173. H. Tadema, W. H. Abdulahad, N. Lepse, C. A. Stegeman, C. G. M. Kallenberg, and P. Heeringa, “Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission,” Rheumatology, vol. 50, no. 4, pp. 689–696, 2011. View at Publisher · View at Google Scholar · View at Scopus
  174. R. A. DeRemee, T. J. McDonald, and L. H. Weiland, “Wegener's granulomatosis: observations on treatment with antimicrobial agents,” Mayo Clinic Proceedings, vol. 60, no. 1, pp. 27–32, 1985. View at Google Scholar · View at Scopus
  175. B. C. West, J. R. Todd, and J. W. King, “Wegener granulomatosis and trimethoprim-sulfamethoxazole: complete remission after a twenty-year course,” Annals of Internal Medicine, vol. 106, no. 6, pp. 840–842, 1987. View at Google Scholar · View at Scopus
  176. H. L. Israel, “Sulfamethoxazole-trimethoprim therapy for Wegener's granulomatosis,” Archives of Internal Medicine, vol. 148, no. 10, pp. 2293–2295, 1988. View at Google Scholar · View at Scopus
  177. C. A. Stegeman, J. W. C. Tervaert, P. E. De Jong, and C. G. M. Kallenberg, “Trimethoprim-sulfamethoxazole (Co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis,” New England Journal of Medicine, vol. 335, no. 1, pp. 16–20, 1996. View at Publisher · View at Google Scholar · View at Scopus
  178. C. G. M. Kallenberg, “What is the evidence for prophylactic antibiotic treatment in patients with systemic vasculitides?” Current Opinion in Rheumatology, vol. 23, no. 3, pp. 311–316, 2011. View at Publisher · View at Google Scholar · View at Scopus
  179. E. R. Popa, C. A. Stegeman, N. A. Bos, C. G. M. Kallenberg, and J. W. Cohen Tervaert, “Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis,” Clinical and Experimental Immunology, vol. 132, no. 3, pp. 496–504, 2003. View at Publisher · View at Google Scholar · View at Scopus
  180. E. R. Popa, C. A. Stegeman, W. H. Abdulahad et al., “Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis,” Rheumatology, vol. 46, no. 6, pp. 1029–1033, 2007. View at Publisher · View at Google Scholar · View at Scopus
  181. W. F. Pendergraft, G. A. Preston, R. R. Shah et al., “Autoimmunity is triggered by cPR-3(105–201), a protein complementary to human autoantigen proteinase-3,” Nature Medicine, vol. 10, no. 1, pp. 72–79, 2004. View at Publisher · View at Google Scholar · View at Scopus
  182. P. Hewins, F. Belmonte, J. Charles Jennette, R. J. Falk, and G. A. Preston, “Longitudinal studies of patients with ANCA vasculitis demonstrate concurrent reactivity to complementary PR3 protein segments cPR3m and cPR3C and with no reactivity to cPR3N,” Autoimmunity, vol. 44, no. 2, pp. 98–106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  183. J. C. Jennette, R. J. Falk, and A. H. Gasim, “Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis,” Current Opinion in Nephrology and Hypertension, vol. 20, no. 3, pp. 263–270, 2011. View at Publisher · View at Google Scholar · View at Scopus
  184. M. H. Zhao, S. J. Jones, and C. M. Lockwood, “Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis,” Clinical and Experimental Immunology, vol. 99, no. 1, pp. 49–56, 1995. View at Google Scholar · View at Scopus
  185. M. H. Zhao and C. M. Lockwood, “Azurocidin is a novel antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in systemic vasculitis,” Clinical and Experimental Immunology, vol. 103, no. 3, pp. 397–402, 1996. View at Google Scholar · View at Scopus
  186. M. P. Stoffel, E. Csernok, C. Herzberg, T. Johnston, S. F. Carroll, and W. L. Gross, “Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders,” Clinical and Experimental Immunology, vol. 104, no. 1, pp. 54–59, 1996. View at Google Scholar · View at Scopus
  187. H. Schultz, “From infection to autoimmunity: a new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI),” Autoimmunity Reviews, vol. 6, no. 4, pp. 223–227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  188. J. J. Yang, R. Tuttle, R. J. Falk, and J. C. Jennette, “Frequency of anti-bactericidal/permeability-increasing protein (BPI) and anti-azurocidin in patients with renal disease,” Clinical and Experimental Immunology, vol. 105, no. 1, pp. 125–131, 1996. View at Google Scholar · View at Scopus
  189. R. Kain, M. Exner, R. Brandes et al., “Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis,” Nature Medicine, vol. 14, no. 10, pp. 1088–1096, 2008. View at Publisher · View at Google Scholar · View at Scopus
  190. X. Bosch and E. Mirapeix, “LAMP-2 illuminates pathogenesis of ANCA glomerulonephritis,” Nature Reviews Nephrology, vol. 5, no. 5, pp. 247–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  191. A. D. Salama and C. D. Pusey, “Shining a LAMP on pauci-immune focal segmental glomerulonephritis,” Kidney International, vol. 76, no. 1, pp. 15–17, 2009. View at Publisher · View at Google Scholar · View at Scopus
  192. A. J. Roth, M. C. Brown, E. N. Smith et al., “Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic antibody glomerulonephritis,” Journal of the American Society of Nephrology, vol. 23, pp. 545–555, 2012. View at Google Scholar
  193. S. M. Flint and C. O. Savage, “Anti-LAMP-2 autoantibodies in ANCA-associated pauci-immune glomerulonephritis,” Journal of the American Society of Nephrology, vol. 23, pp. 378–380, 2012. View at Google Scholar
  194. V. Brinkmann, U. Reichard, C. Goosmann et al., “Neutrophil extracellular traps kill bacteria,” Science, vol. 303, no. 5663, pp. 1532–1535, 2004. View at Publisher · View at Google Scholar · View at Scopus
  195. T. A. Fuchs, U. Abed, C. Goosmann et al., “Novel cell death program leads to neutrophil extracellular traps,” Journal of Cell Biology, vol. 176, no. 2, pp. 231–241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  196. K. Kessenbrock, M. Krumbholz, U. Schönermarck et al., “Netting neutrophils in autoimmune small-vessel vasculitis,” Nature Medicine, vol. 15, no. 6, pp. 623–625, 2009. View at Publisher · View at Google Scholar · View at Scopus
  197. X. Bosch, “LAMPs and NETs in the pathogenesis of ANCA vasculitis,” Journal of the American Society of Nephrology, vol. 20, no. 8, pp. 1654–1656, 2009. View at Publisher · View at Google Scholar · View at Scopus
  198. T. Kawai and S. Akira, “The role of pattern-recognition receptors in innate immunity: update on toll-like receptors,” Nature Immunology, vol. 11, no. 5, pp. 373–384, 2010. View at Publisher · View at Google Scholar · View at Scopus
  199. H. Tadema, W. H. Abdulahad, N. Lepse, C. A. Stegeman, C. G. M. Kallenberg, and P. Heeringa, “Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission,” Rheumatology, vol. 50, no. 4, pp. 689–696, 2011. View at Publisher · View at Google Scholar · View at Scopus
  200. H. Tadema, W. H. Abdulahad, C. A. Stegeman, C. G. M. Kallenberg, and P. Heeringa, “Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitis,” PLoS One, vol. 6, no. 9, Article ID e24315, 2011. View at Google Scholar
  201. H. Morris, M. D. Morgan, A. M. Wood et al., “ANCA-associated vasculitis is linked to carriage of the Z allele of α1 antitrypsin and its polymers,” Annals of the Rheumatic Diseases, vol. 70, pp. 1851–1856, 2011. View at Google Scholar
  202. P. A. Lyons, T. F. Rayner, S. Trivedi et al., “Genetically distinct subsets within ANCA-associated vasculitis,” New England Journal of Medicine, vol. 367, pp. 214–223, 2012. View at Google Scholar
  203. D. Martorana, F. Maritati, and G. Malebra, “PTRN22 R620W polymorphism in the ANCA-associated vasculitides,” Rheumatology, vol. 51, pp. 805–812, 2012. View at Google Scholar
  204. L. C. Willcocks, P. A. Lyons, A. J. Rees, and K. G. C. Smith, “The contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitis,” Arthritis Research and Therapy, vol. 12, no. 1, article 202, 2010. View at Publisher · View at Google Scholar · View at Scopus